adstiladrin

Generic: nadofaragene firadenovec-vncg

Labeler: ferring pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name adstiladrin
Generic Name nadofaragene firadenovec-vncg
Labeler ferring pharmaceuticals inc.
Dosage Form SUSPENSION
Routes
INTRAVESICAL
Active Ingredients

nadofaragene firadenovec 300000000000 {VP}/mL

Manufacturer
Ferring Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 55566-1050
Product ID 55566-1050_a47aadc2-f4fa-4ac5-b5de-7d9d707b381b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125700
Listing Expiration 2026-12-31
Marketing Start 2023-09-05

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 555661050
Hyphenated Format 55566-1050

Supplemental Identifiers

RxCUI
2644440 2644445
UNII
0OOS09O1FH

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name adstiladrin (source: ndc)
Generic Name nadofaragene firadenovec-vncg (source: ndc)
Application Number BLA125700 (source: ndc)
Routes
INTRAVESICAL
source: ndc

Resolved Composition

Strengths
  • 300000000000 {VP}/mL
source: ndc
Packaging
  • 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL (55566-1050-0)
  • 20 mL in 1 VIAL (55566-1050-2)
source: ndc

Packages (2)

55566-1050-1 4 VIAL in 1 CARTON (55566-1050-1) / 20 mL in 1 VIAL (55566-1050-0) 55566-1050-2 20 mL in 1 VIAL (55566-1050-2)

Ingredients (1)

nadofaragene firadenovec (300000000000 {VP}/mL)

Linked Drug Pages (1)

ADSTILADRIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVESICAL"], "spl_id": "a47aadc2-f4fa-4ac5-b5de-7d9d707b381b", "openfda": {"unii": ["0OOS09O1FH"], "rxcui": ["2644440", "2644445"], "spl_set_id": ["5ca20ed4-da4f-463c-ac2a-ccd6ab3774fa"], "manufacturer_name": ["Ferring Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (55566-1050-1)  / 20 mL in 1 VIAL (55566-1050-0)", "package_ndc": "55566-1050-1", "marketing_start_date": "20230905"}, {"sample": false, "description": "20 mL in 1 VIAL (55566-1050-2)", "package_ndc": "55566-1050-2", "marketing_start_date": "20251013"}], "brand_name": "ADSTILADRIN", "product_id": "55566-1050_a47aadc2-f4fa-4ac5-b5de-7d9d707b381b", "dosage_form": "SUSPENSION", "product_ndc": "55566-1050", "generic_name": "nadofaragene firadenovec-vncg", "labeler_name": "Ferring Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ADSTILADRIN", "active_ingredients": [{"name": "NADOFARAGENE FIRADENOVEC", "strength": "300000000000 {VP}/mL"}], "application_number": "BLA125700", "marketing_category": "BLA", "marketing_start_date": "20230905", "listing_expiration_date": "20261231"}